OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2022
(5)
2021
(3)
2020
(3)
2011
(2)
2025
(1)
2018
(1)
2017
(1)
2014
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Response to 2009 pandemic influenza A (H1N1) vaccine in HIV-infected patients and the influence of prior seasonal influenza vaccination.
Not available
S-EPMC3031580
|
biostudies-literature
Cite
Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury.
Not available
S-EPMC7898424
|
biostudies-literature
Cite
Change in Urinary Myoinositol/Citrate Ratio Associates with Progressive Loss of Renal Function in ADPKD Patients.
Not available
S-EPMC9393825
|
biostudies-literature
Cite
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.
Not available
S-EPMC7244119
|
biostudies-literature
Cite
Efficacy and safety of selective decontamination of the digestive tract (SDD) to prevent recurrent hepatic cyst infections in polycystic liver disease: a retrospective case series.
Not available
S-EPMC7443730
|
biostudies-literature
Cite
The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery.
Not available
S-EPMC7806984
|
biostudies-literature
Cite
Elderly subjects have a delayed antibody response and prolonged viraemia following yellow fever vaccination: a prospective controlled cohort study.
Not available
S-EPMC3233541
|
biostudies-literature
Cite
Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients.
Not available
S-EPMC9245319
|
biostudies-literature
Cite
ExploriNg DUrable Remission with Rituximab in ANCA-associatEd vasculitis (ENDURRANCE trial): protocol for a randomised controlled trial.
Not available
S-EPMC9494556
|
biostudies-literature
Cite
Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial.
Not available
S-EPMC9652788
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets